Screener
BioLife Solutions BLFS CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: BioLife Solutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:22 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054355
| (In thousands) | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Proceeds from sale of available-for-sale securities | 4,690 | 1,755 |
| Maturities of available-for-sale securities | 28,586 | 8,390 |
| Purchases of assets held for rent | — | (412) |
| Purchases of property and equipment | (1,210) | (1,918) |
| Investment in IPR&D | — | (10,221) |
| Purchase of intangible assets | (120) | — |
| Net cash used in investing activities | (3,409) | (66,709) |
| Cash flows from financing activities |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is BioLife Solutions's capex?
- BioLife Solutions (BLFS) reported capex of $1.04M in Q2 2026.
- How has BioLife Solutions's capex changed year-over-year?
- BioLife Solutions's capex decreased by 40.2% year-over-year, from $1.74M to $1.04M.
- What is the long-term trend for BioLife Solutions's capex?
- Over 3 years (2021 to 2024), BioLife Solutions's capex has grown at a -25.8% compound annual growth rate (CAGR), from $8.39M to $3.43M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about BioLife Solutions's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude